- IBDEI10M ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,16511,1,4,0)
- ;;=4^C82.39
- ;;^UTILITY(U,$J,358.3,16511,2)
- ;;=^5001500
- ;;^UTILITY(U,$J,358.3,16512,0)
- ;;=C82.30^^61^775^76
- ;;^UTILITY(U,$J,358.3,16512,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16512,1,3,0)
- ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
- ;;^UTILITY(U,$J,358.3,16512,1,4,0)
- ;;=4^C82.30
- ;;^UTILITY(U,$J,358.3,16512,2)
- ;;=^5001491
- ;;^UTILITY(U,$J,358.3,16513,0)
- ;;=C82.49^^61^775^77
- ;;^UTILITY(U,$J,358.3,16513,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16513,1,3,0)
- ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
- ;;^UTILITY(U,$J,358.3,16513,1,4,0)
- ;;=4^C82.49
- ;;^UTILITY(U,$J,358.3,16513,2)
- ;;=^5001510
- ;;^UTILITY(U,$J,358.3,16514,0)
- ;;=C82.40^^61^775^78
- ;;^UTILITY(U,$J,358.3,16514,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16514,1,3,0)
- ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
- ;;^UTILITY(U,$J,358.3,16514,1,4,0)
- ;;=4^C82.40
- ;;^UTILITY(U,$J,358.3,16514,2)
- ;;=^5001501
- ;;^UTILITY(U,$J,358.3,16515,0)
- ;;=C82.99^^61^775^79
- ;;^UTILITY(U,$J,358.3,16515,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16515,1,3,0)
- ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
- ;;^UTILITY(U,$J,358.3,16515,1,4,0)
- ;;=4^C82.99
- ;;^UTILITY(U,$J,358.3,16515,2)
- ;;=^5001550
- ;;^UTILITY(U,$J,358.3,16516,0)
- ;;=C82.90^^61^775^80
- ;;^UTILITY(U,$J,358.3,16516,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16516,1,3,0)
- ;;=3^Follicular Lymphoma Unspec,Unspec Site
- ;;^UTILITY(U,$J,358.3,16516,1,4,0)
- ;;=4^C82.90
- ;;^UTILITY(U,$J,358.3,16516,2)
- ;;=^5001541
- ;;^UTILITY(U,$J,358.3,16517,0)
- ;;=R59.1^^61^775^65
- ;;^UTILITY(U,$J,358.3,16517,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16517,1,3,0)
- ;;=3^Enlarged Lymph Nodes,Generalized
- ;;^UTILITY(U,$J,358.3,16517,1,4,0)
- ;;=4^R59.1
- ;;^UTILITY(U,$J,358.3,16517,2)
- ;;=^5019530
- ;;^UTILITY(U,$J,358.3,16518,0)
- ;;=C91.40^^61^775^84
- ;;^UTILITY(U,$J,358.3,16518,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16518,1,3,0)
- ;;=3^Hairy Cell Leukemia,Not in Remission
- ;;^UTILITY(U,$J,358.3,16518,1,4,0)
- ;;=4^C91.40
- ;;^UTILITY(U,$J,358.3,16518,2)
- ;;=^5001771
- ;;^UTILITY(U,$J,358.3,16519,0)
- ;;=C91.42^^61^775^82
- ;;^UTILITY(U,$J,358.3,16519,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16519,1,3,0)
- ;;=3^Hairy Cell Leukemia,In Relapse
- ;;^UTILITY(U,$J,358.3,16519,1,4,0)
- ;;=4^C91.42
- ;;^UTILITY(U,$J,358.3,16519,2)
- ;;=^5001773
- ;;^UTILITY(U,$J,358.3,16520,0)
- ;;=C91.41^^61^775^83
- ;;^UTILITY(U,$J,358.3,16520,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16520,1,3,0)
- ;;=3^Hairy Cell Leukemia,In Remission
- ;;^UTILITY(U,$J,358.3,16520,1,4,0)
- ;;=4^C91.41
- ;;^UTILITY(U,$J,358.3,16520,2)
- ;;=^5001772
- ;;^UTILITY(U,$J,358.3,16521,0)
- ;;=D57.01^^61^775^85
- ;;^UTILITY(U,$J,358.3,16521,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16521,1,3,0)
- ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
- ;;^UTILITY(U,$J,358.3,16521,1,4,0)
- ;;=4^D57.01
- ;;^UTILITY(U,$J,358.3,16521,2)
- ;;=^5002307
- ;;^UTILITY(U,$J,358.3,16522,0)
- ;;=D57.00^^61^775^86
- ;;^UTILITY(U,$J,358.3,16522,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16522,1,3,0)
- ;;=3^Hb-SS Disease w/ Crisis,Unspec
- ;;^UTILITY(U,$J,358.3,16522,1,4,0)
- ;;=4^D57.00
- ;;^UTILITY(U,$J,358.3,16522,2)
- ;;=^5002306
- ;;^UTILITY(U,$J,358.3,16523,0)
- ;;=D57.02^^61^775^87
- ;;^UTILITY(U,$J,358.3,16523,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16523,1,3,0)
- ;;=3^Hb-SS Disease w/ Splenic Sequestration
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10M 3761 printed Feb 18, 2025@23:25:47 Page 2
- IBDEI10M ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,16511,1,4,0)
- +2 ;;=4^C82.39
- +3 ;;^UTILITY(U,$J,358.3,16511,2)
- +4 ;;=^5001500
- +5 ;;^UTILITY(U,$J,358.3,16512,0)
- +6 ;;=C82.30^^61^775^76
- +7 ;;^UTILITY(U,$J,358.3,16512,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,16512,1,3,0)
- +10 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
- +11 ;;^UTILITY(U,$J,358.3,16512,1,4,0)
- +12 ;;=4^C82.30
- +13 ;;^UTILITY(U,$J,358.3,16512,2)
- +14 ;;=^5001491
- +15 ;;^UTILITY(U,$J,358.3,16513,0)
- +16 ;;=C82.49^^61^775^77
- +17 ;;^UTILITY(U,$J,358.3,16513,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,16513,1,3,0)
- +20 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
- +21 ;;^UTILITY(U,$J,358.3,16513,1,4,0)
- +22 ;;=4^C82.49
- +23 ;;^UTILITY(U,$J,358.3,16513,2)
- +24 ;;=^5001510
- +25 ;;^UTILITY(U,$J,358.3,16514,0)
- +26 ;;=C82.40^^61^775^78
- +27 ;;^UTILITY(U,$J,358.3,16514,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,16514,1,3,0)
- +30 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
- +31 ;;^UTILITY(U,$J,358.3,16514,1,4,0)
- +32 ;;=4^C82.40
- +33 ;;^UTILITY(U,$J,358.3,16514,2)
- +34 ;;=^5001501
- +35 ;;^UTILITY(U,$J,358.3,16515,0)
- +36 ;;=C82.99^^61^775^79
- +37 ;;^UTILITY(U,$J,358.3,16515,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,16515,1,3,0)
- +40 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
- +41 ;;^UTILITY(U,$J,358.3,16515,1,4,0)
- +42 ;;=4^C82.99
- +43 ;;^UTILITY(U,$J,358.3,16515,2)
- +44 ;;=^5001550
- +45 ;;^UTILITY(U,$J,358.3,16516,0)
- +46 ;;=C82.90^^61^775^80
- +47 ;;^UTILITY(U,$J,358.3,16516,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,16516,1,3,0)
- +50 ;;=3^Follicular Lymphoma Unspec,Unspec Site
- +51 ;;^UTILITY(U,$J,358.3,16516,1,4,0)
- +52 ;;=4^C82.90
- +53 ;;^UTILITY(U,$J,358.3,16516,2)
- +54 ;;=^5001541
- +55 ;;^UTILITY(U,$J,358.3,16517,0)
- +56 ;;=R59.1^^61^775^65
- +57 ;;^UTILITY(U,$J,358.3,16517,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,16517,1,3,0)
- +60 ;;=3^Enlarged Lymph Nodes,Generalized
- +61 ;;^UTILITY(U,$J,358.3,16517,1,4,0)
- +62 ;;=4^R59.1
- +63 ;;^UTILITY(U,$J,358.3,16517,2)
- +64 ;;=^5019530
- +65 ;;^UTILITY(U,$J,358.3,16518,0)
- +66 ;;=C91.40^^61^775^84
- +67 ;;^UTILITY(U,$J,358.3,16518,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,16518,1,3,0)
- +70 ;;=3^Hairy Cell Leukemia,Not in Remission
- +71 ;;^UTILITY(U,$J,358.3,16518,1,4,0)
- +72 ;;=4^C91.40
- +73 ;;^UTILITY(U,$J,358.3,16518,2)
- +74 ;;=^5001771
- +75 ;;^UTILITY(U,$J,358.3,16519,0)
- +76 ;;=C91.42^^61^775^82
- +77 ;;^UTILITY(U,$J,358.3,16519,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,16519,1,3,0)
- +80 ;;=3^Hairy Cell Leukemia,In Relapse
- +81 ;;^UTILITY(U,$J,358.3,16519,1,4,0)
- +82 ;;=4^C91.42
- +83 ;;^UTILITY(U,$J,358.3,16519,2)
- +84 ;;=^5001773
- +85 ;;^UTILITY(U,$J,358.3,16520,0)
- +86 ;;=C91.41^^61^775^83
- +87 ;;^UTILITY(U,$J,358.3,16520,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,16520,1,3,0)
- +90 ;;=3^Hairy Cell Leukemia,In Remission
- +91 ;;^UTILITY(U,$J,358.3,16520,1,4,0)
- +92 ;;=4^C91.41
- +93 ;;^UTILITY(U,$J,358.3,16520,2)
- +94 ;;=^5001772
- +95 ;;^UTILITY(U,$J,358.3,16521,0)
- +96 ;;=D57.01^^61^775^85
- +97 ;;^UTILITY(U,$J,358.3,16521,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,16521,1,3,0)
- +100 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
- +101 ;;^UTILITY(U,$J,358.3,16521,1,4,0)
- +102 ;;=4^D57.01
- +103 ;;^UTILITY(U,$J,358.3,16521,2)
- +104 ;;=^5002307
- +105 ;;^UTILITY(U,$J,358.3,16522,0)
- +106 ;;=D57.00^^61^775^86
- +107 ;;^UTILITY(U,$J,358.3,16522,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,16522,1,3,0)
- +110 ;;=3^Hb-SS Disease w/ Crisis,Unspec
- +111 ;;^UTILITY(U,$J,358.3,16522,1,4,0)
- +112 ;;=4^D57.00
- +113 ;;^UTILITY(U,$J,358.3,16522,2)
- +114 ;;=^5002306
- +115 ;;^UTILITY(U,$J,358.3,16523,0)
- +116 ;;=D57.02^^61^775^87
- +117 ;;^UTILITY(U,$J,358.3,16523,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,16523,1,3,0)
- +120 ;;=3^Hb-SS Disease w/ Splenic Sequestration